CY2038B1 - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number: CY2038B1
Authority: CY; Cyprus
Prior art keywords: indole derivatives; indole; derivatives
Prior art date: 1992-04-16

Application number

CY9802038A

Other languages

English (en)

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-16

Filing date

1998-04-30

Publication date

1998-04-30

1998-04-30 Application filed by Glaxo Spa filed Critical Glaxo Spa

1998-04-30 Publication of CY2038B1 publication Critical patent/CY2038B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

CY9802038A 1992-04-16 1998-04-30 Indole derivatives CY2038B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929208492A GB9208492D0 (en)	1992-04-16	1992-04-16	Heterocyclic compounds

Publications (1)

Publication Number	Publication Date
CY2038B1 true CY2038B1 (en)	1998-04-30

Family

ID=10714220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY9802038A CY2038B1 (en)	1992-04-16	1998-04-30	Indole derivatives

Country Status (41)

Country	Link
US (4)	US5373018A (fr)
EP (1)	EP0568136A1 (fr)
JP (2)	JPH07505407A (fr)
KR (1)	KR100264114B1 (fr)
CN (1)	CN1042331C (fr)
AP (1)	AP480A (fr)
AT (1)	AT403917B (fr)
AU (1)	AU666927B2 (fr)
BE (1)	BE1006343A5 (fr)
BG (1)	BG62136B1 (fr)
BR (1)	BR1100323A (fr)
CA (3)	CA2094076A1 (fr)
CH (1)	CH685630A5 (fr)
CY (1)	CY2038B1 (fr)
CZ (1)	CZ285799B6 (fr)
DK (1)	DK169890B1 (fr)
ES (1)	ES2105924B1 (fr)
FI (1)	FI106198B (fr)
FR (1)	FR2690919B1 (fr)
GB (2)	GB9208492D0 (fr)
GE (1)	GEP19991704B (fr)
GR (1)	GR1001619B (fr)
HK (1)	HK95797A (fr)
HU (2)	HU217964B (fr)
IL (1)	IL105412A (fr)
IS (1)	IS3994A (fr)
IT (1)	IT1265325B1 (fr)
LU (1)	LU88248A1 (fr)
MX (1)	MX9302195A (fr)
MY (1)	MY112232A (fr)
NO (1)	NO301879B1 (fr)
NZ (1)	NZ247413A (fr)
OA (1)	OA10103A (fr)
PL (1)	PL176451B1 (fr)
RO (1)	RO113242B1 (fr)
RU (1)	RU2129544C1 (fr)
SE (1)	SE504336C2 (fr)
SK (1)	SK281941B6 (fr)
TW (1)	TW224457B (fr)
WO (1)	WO1993021153A1 (fr)
ZA (1)	ZA932642B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9304500D0 (en) *	1993-03-05	1993-04-21	Glaxo Spa	Heterocyclic compounds
US5519048A (en) *	1993-05-27	1996-05-21	Merrell Pharmaceuticals Inc.	3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
ES2103590T3 (es) *	1993-05-27	1997-09-16	Merrell Pharma Inc	Derivados del acido 3-(indol-3-il) propenoico utilizables como antagonistas nmda.
GB9319243D0 (en) *	1993-09-17	1993-11-03	Glaxo Spa	Heterocyclic compounds
GB9321221D0 (en) *	1993-10-14	1993-12-01	Glaxo Spa	Heterocyclic compounds
TW280819B (fr) *	1993-11-17	1996-07-11	Sumitomo Pharma
US5563157B1 (en)	1994-10-31	1999-02-02	Hoecst Marion Roussel Inc	Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) *	1995-02-11	1995-03-29	Glaxo Spa	Pharmaceutical composition
GB9504361D0 (en) *	1995-03-04	1995-04-26	Glaxo Spa	Heterocyclic compounds
WO1998011892A1 (fr) *	1996-09-17	1998-03-26	The Regents Of The University Of California	Modulation positive du recepteur ampa permettant d'ameliorer l'expression des facteurs neurotrophiques dans le cerveau
CN1139572C (zh) *	1996-09-30	2004-02-25	阿温蒂斯药物公司	Nmda(n-甲基-d-天冬氨酸)拮抗剂
US5922752A (en) *	1997-06-11	1999-07-13	Hoechst Marion Roussell, Inc.	NMDA (n-methyl-d-aspartate) antagonists
AU749623B2 (en) *	1998-03-26	2002-06-27	Astellas Pharma Inc.	Sustained release preparations
RU2277096C2 (ru) *	2000-07-31	2006-05-27	ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД.	Средства против слабоумия, содержащие производное 2-арил-8-оксодигидропурина в качестве активного ингредиента
US20030162825A1 (en) *	2001-11-09	2003-08-28	Sepracor Inc.	D-amino acid oxidase inhibitors for learning and memory
PL373484A1 (en) *	2001-12-10	2005-09-05	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
PA8579701A1 (es) *	2002-08-23	2005-05-24	Pfizer Prod Inc	Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) *	2003-02-13	2004-08-26	Grünenthal GmbH	Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
EP1636240A1 (fr) *	2003-06-05	2006-03-22	Pfizer Products Inc.	Promedicament inhibiteur de la beta-lactamase
RU2247563C1 (ru) *	2003-06-16	2005-03-10	Пятигорская государственная фармацевтическая академия	Способ получения твердой лекарственной формы, содержащей глюкозамина гидрохлорид
ATE473967T1 (de) *	2003-11-26	2010-07-15	Pfizer Prod Inc	Aminopyrazolderivate als gsk-3-inhibitoren
CA2551952A1 (fr) *	2003-12-29	2005-07-21	Sepracor Inc.	Inhibiteurs daao de pyrrole et de pyrazole
RU2281755C2 (ru) *	2004-04-19	2006-08-20	Пятигорская государственная фармацевтическая академия	Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для ректального применения
US20060002999A1 (en) *	2004-06-17	2006-01-05	Forest Laboratories, Inc.	Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP1904066B1 (fr)	2005-07-06	2018-05-23	Sunovion Pharmaceuticals Inc.	COMBINAISONS D'ESZOPICLONE ET DE TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTALENAMINE, pour le TRAITEMENT DE LA MENOPAUSE, perimenopause ET des TROUBLES COGNITIFS
CA2636324C (fr) *	2006-01-06	2012-03-20	Sepracor Inc.	Cycloalkylamines inhibiteurs du recaptage des monoamines
WO2007081542A2 (fr) *	2006-01-06	2007-07-19	Sepracor Inc.	Inhibiteurs de recaptage de monoamine a base de tetralone
DK2013835T3 (en)	2006-03-31	2015-12-14	Sunovion Pharmaceuticals Inc	Preparation of chiral amides and AMINES
US7579370B2 (en) *	2006-06-30	2009-08-25	Sepracor Inc.	Fused heterocycles
US7884124B2 (en) *	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) *	2006-10-02	2008-04-03	Weyerhaeuser Co.	Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (fr)	2006-12-20	2008-07-09	sanofi-aventis	Hétéroarylcyclopropanecarboxamide et leur utilisation pharmaceutique
US7902252B2 (en) *	2007-01-18	2011-03-08	Sepracor, Inc.	Inhibitors of D-amino acid oxidase
ZA200904686B (en)	2007-01-18	2010-09-29	Sepracor Inc	Inhibitiors of D-amino acid oxidase
RU2470011C2 (ru)	2007-05-31	2012-12-20	Сепракор Инк.	Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
WO2009151498A2 (fr) *	2008-03-28	2009-12-17	Forest Laboratories Holdings Limited	Formulations de mémantine
US20100120740A1 (en) *	2008-08-07	2010-05-13	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110319463A1 (en) *	2009-03-10	2011-12-29	Saten Pharamaceuticals Co., Ltd.	Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
US20110034434A1 (en) *	2009-08-07	2011-02-10	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en)	2012-07-12	2017-08-22	Glytech, Llc	Composition and method for treatment of depression and psychosis in humans
AU2015253099B2 (en)	2014-04-30	2019-07-18	National Chiao Tung University	Use of known compounds as D-amino acid oxidase inhibitors
CN110234635B (zh)	2016-09-14	2023-03-10	宇凤·简·曾	作为d-胺基酸氧化酶(daao)抑制剂之新颖经取代苯并咪唑衍生物
AU2018284335A1 (en)	2017-06-12	2020-01-30	Glytech Llc.	Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists
CN112707874A (zh) *	2020-12-29	2021-04-27	广东中科药物研究有限公司	一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3010971A (en) *	1960-08-04	1961-11-28	Smith Kline French Lab	Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) *	1984-11-02	1986-05-03	Glaxo Group Ltd	Cephalosporinantibiotika
US4960786A (en) *	1989-04-24	1990-10-02	Merrell Dow Pharmaceuticals Inc.	Excitatory amino acid antagonists
JPH0347123A (ja) *	1989-05-05	1991-02-28	G D Searle & Co	インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
DE69118539T2 (de) *	1990-07-16	1996-09-19	Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio	Exzitatorische Aminosäureantagonisten
US5284862A (en) *	1991-03-18	1994-02-08	Warner-Lambert Company	Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) *	1991-05-14	1992-09-08	Warner-Lambert Co.	Substituted 2-carboxylindoles having pharmaceutical activity

1992
- 1992-04-16 GB GB929208492A patent/GB9208492D0/en active Pending
1993
- 1993-04-14 ZA ZA932642A patent/ZA932642B/xx unknown
- 1993-04-15 AU AU36923/93A patent/AU666927B2/en not_active Ceased
- 1993-04-15 US US08/046,947 patent/US5373018A/en not_active Expired - Fee Related
- 1993-04-15 JP JP5517997A patent/JPH07505407A/ja active Pending
- 1993-04-15 CH CH1133/93A patent/CH685630A5/fr not_active IP Right Cessation
- 1993-04-15 NZ NZ247413A patent/NZ247413A/en unknown
- 1993-04-15 MY MYPI93000690A patent/MY112232A/en unknown
- 1993-04-15 EP EP93201103A patent/EP0568136A1/fr not_active Withdrawn
- 1993-04-15 IS IS3994A patent/IS3994A/is unknown
- 1993-04-15 CA CA002094076A patent/CA2094076A1/fr not_active Abandoned
- 1993-04-15 SE SE9301241A patent/SE504336C2/sv not_active IP Right Cessation
- 1993-04-15 RU RU94045915A patent/RU2129544C1/ru active
- 1993-04-15 BE BE9300371A patent/BE1006343A5/fr active
- 1993-04-15 CZ CZ942543A patent/CZ285799B6/cs not_active IP Right Cessation
- 1993-04-15 US US08/047,430 patent/US5374649A/en not_active Expired - Fee Related
- 1993-04-15 PL PL93305554A patent/PL176451B1/pl unknown
- 1993-04-15 SK SK1241-94A patent/SK281941B6/sk unknown
- 1993-04-15 GR GR930100154A patent/GR1001619B/el not_active IP Right Cessation
- 1993-04-15 WO PCT/EP1993/000938 patent/WO1993021153A1/fr not_active Ceased
- 1993-04-15 LU LU88248A patent/LU88248A1/fr unknown
- 1993-04-15 FR FR9304452A patent/FR2690919B1/fr not_active Expired - Fee Related
- 1993-04-15 JP JP5088844A patent/JPH0649027A/ja active Pending
- 1993-04-15 IL IL105412A patent/IL105412A/en not_active IP Right Cessation
- 1993-04-15 KR KR1019940703668A patent/KR100264114B1/ko not_active Expired - Fee Related
- 1993-04-15 DK DK043193A patent/DK169890B1/da active
- 1993-04-15 GB GB9307808A patent/GB2266091B/en not_active Expired - Fee Related
- 1993-04-15 CA CA002094075A patent/CA2094075A1/fr not_active Abandoned
- 1993-04-15 AT AT0075293A patent/AT403917B/de not_active IP Right Cessation
- 1993-04-15 CA CA002094073A patent/CA2094073A1/fr not_active Abandoned
- 1993-04-15 ES ES09300771A patent/ES2105924B1/es not_active Expired - Lifetime
- 1993-04-15 HU HU9402975A patent/HU217964B/hu not_active IP Right Cessation
- 1993-04-15 IT IT93RM000236A patent/IT1265325B1/it active IP Right Grant
- 1993-04-15 MX MX9302195A patent/MX9302195A/es not_active IP Right Cessation
- 1993-04-15 US US08/047,429 patent/US5374648A/en not_active Expired - Fee Related
- 1993-04-15 CN CN93105797A patent/CN1042331C/zh not_active Expired - Fee Related
- 1993-04-15 RO RO94-01658A patent/RO113242B1/ro unknown
- 1993-04-16 AP APAP/P/1993/000524A patent/AP480A/en active
- 1993-04-16 GE GEAP19932602A patent/GEP19991704B/en unknown
- 1993-05-06 TW TW082103531A patent/TW224457B/zh active
1994
- 1994-10-10 OA OA60570A patent/OA10103A/en unknown
- 1994-10-12 FI FI944800A patent/FI106198B/fi active
- 1994-10-14 NO NO943913A patent/NO301879B1/no not_active IP Right Cessation
- 1994-10-14 BG BG99111A patent/BG62136B1/bg unknown
- 1994-12-08 US US08/351,762 patent/US5510367A/en not_active Expired - Fee Related
1995
- 1995-06-29 HU HU95P/P00538P patent/HU211826A9/hu unknown
1997
- 1997-04-22 BR BR1100323-5A patent/BR1100323A/pt active IP Right Grant
- 1997-06-26 HK HK95797A patent/HK95797A/xx not_active IP Right Cessation
1998
- 1998-04-30 CY CY9802038A patent/CY2038B1/xx unknown

Also Published As

Publication number	Publication date
GB2266091B (en)	1995-08-09
RU94045915A (ru)	1996-09-10
ITRM930236A1 (it)	1994-10-15
EP0568136A1 (fr)	1993-11-03
CA2094073A1 (fr)	1993-10-17
CN1085212A (zh)	1994-04-13
GB2266091A (en)	1993-10-20
ZA932642B (en)	1994-01-10
SE9301241L (sv)	1993-10-17
GEP19991704B (en)	1999-08-05
DK43193A (da)	1993-10-17
GB9208492D0 (en)	1992-06-03
CN1042331C (zh)	1999-03-03
DK43193D0 (da)	1993-04-15
RO113242B1 (ro)	1998-05-29
NO301879B1 (no)	1997-12-22
ITRM930236A0 (it)	1993-04-15
NO943913L (no)	1994-12-14
MY112232A (en)	2001-05-31
IS3994A (is)	1993-10-17
AU3692393A (en)	1993-10-21
SE9301241D0 (sv)	1993-04-15
FI944800L (fi)	1994-10-12
AU666927B2 (en)	1996-02-29
HU9402975D0 (en)	1995-02-28
GR1001619B (el)	1994-07-29
CZ285799B6 (cs)	1999-11-17
BE1006343A5 (fr)	1994-07-26
IT1265325B1 (it)	1996-10-31
CH685630A5 (fr)	1995-08-31
WO1993021153A1 (fr)	1993-10-28
IL105412A0 (en)	1993-08-18
JPH0649027A (ja)	1994-02-22
US5374648A (en)	1994-12-20
ATA75293A (de)	1997-11-15
LU88248A1 (fr)	1994-03-01
CA2094075A1 (fr)	1993-10-17
TW224457B (fr)	1994-06-01
BR1100323A (pt)	2000-06-27
MX9302195A (es)	1994-03-31
ES2105924B1 (es)	1998-07-01
AP9300524A0 (en)	1993-04-30
JPH07505407A (ja)	1995-06-15
BG99111A (bg)	1995-05-31
GB9307808D0 (en)	1993-06-02
AP480A (en)	1996-03-22
CA2094076A1 (fr)	1993-10-17
RU2129544C1 (ru)	1999-04-27
DK169890B1 (da)	1995-03-27
IL105412A (en)	1998-02-22
US5510367A (en)	1996-04-23
OA10103A (en)	1996-12-18
BG62136B1 (bg)	1999-03-31
FR2690919A1 (fr)	1993-11-12
SE504336C2 (sv)	1997-01-13
NZ247413A (en)	1995-12-21
CZ254394A3 (en)	1995-07-12
FR2690919B1 (fr)	1995-05-05
PL176451B1 (pl)	1999-05-31
FI944800A0 (fi)	1994-10-12
SK124194A3 (en)	1995-05-10
ES2105924A1 (es)	1997-10-16
NO943913D0 (no)	1994-10-14
US5374649A (en)	1994-12-20
KR100264114B1 (ko)	2000-11-01
US5373018A (en)	1994-12-13
FI106198B (fi)	2000-12-15
AT403917B (de)	1998-06-25
HU217964B (hu)	2000-05-28
HK95797A (en)	1997-08-08
HU211826A9 (en)	1995-12-28
SK281941B6 (sk)	2001-09-11
HUT70526A (en)	1995-10-30

Publication	Publication Date	Title
GB2266091B (en)	1995-08-09	Indole derivatives
HU9301003D0 (en)	1993-06-28	Indole derivatives
GB2251614B (en)	1994-12-14	Indole derivatives
ZA942383B (en)	1995-10-09	New indole derivatives
ZA932582B (en)	1994-10-13	Indoles
ZA941483B (en)	1994-11-11	Indole derivatives
PL313969A1 (en)	1996-08-05	Indole derivatives
GB9326332D0 (en)	1994-02-23	Indole derivatives
GB9319297D0 (en)	1993-11-03	Indole derivatives
HU9201550D0 (en)	1992-07-28	Indole derivatives
IL109376A0 (en)	1994-07-31	Indole derivatives
GB9116732D0 (en)	1991-09-18	Indole derivatives
GB9204024D0 (en)	1992-04-08	Indole derivatives
GB9310092D0 (en)	1993-06-30	Indole derivatives
GB9302577D0 (en)	1993-03-24	Indole derivatives
GB9218595D0 (en)	1992-10-14	Indole derivatives
GB9206809D0 (en)	1992-05-13	Indole derivatives
GB9206056D0 (en)	1992-05-06	Indole derivatives
GB9215961D0 (en)	1992-09-09	Indole derivatives
GB9206787D0 (en)	1992-05-13	Indole derivatives
IL121326A0 (en)	1998-01-04	Indole derivatives
GB9206794D0 (en)	1992-05-13	Indole derivatives
GB9206810D0 (en)	1992-05-13	Indole derivatives
GB9309148D0 (en)	1993-06-16	Indole derivatives
GB9319299D0 (en)	1993-11-03	Indole derivatives